PRESCRIPTION DRUG ALERT:  Pfizer's Arthritis Drug Bextra Withdrawn from Pharmaceutical Market Amid Health Concerns and Side Effects.
Missouri Prescription Drug Bextra Attorneys - Negligence & Injury Attorneys - Brown & Crouppen Bextra Information Header Bextra - Attorneys .com - St. Louis, MO Law Firm
Bextra Prescription Drug Information - Side Effects & Dangers
 

 
Bextra is a prescription pain management drug usually prescribed for patients suffering with arthritis, acute pain management, and severe menstrual symptoms. Bextra, a pharmaceutical medication, is in a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Other NSAIDs including Vioxx and Celebrex.

An FDA (Food & Drug Administration) advisory panel has been studying the drug safety and risky side effects associated with Bextra, Vioxx and Celebrex. The latest FDA recommendations regarding the sale and labeling of NSAIDs can be found here: http://www.fda.gov/cder/drug/infopage/COX2/default.htm

The FDA's recommendations include a request that pharmaceutical manufacturer Pfizer halt the sale of Bextra (April 7, 2005). The release states that the health risks associated with Bextra outweigh the drug's benefits.

"We have concluded that, from a public health perspective, we must assume that Bextra has an increased risk of CV events with long-term use. This conclusion is strongly supported by the significant increase in CV risk seen in those patients who had just undergone heart surgery and the fact that other COX-2 selective NSAIDs have demonstrated such increased CV risk in long-term studies." - FDA.gov

FDA has also asked Pfizer to include a boxed warning in the Celebrex (celecoxib) label. FDA is asking manufacturers of all other prescription NSAIDs to revise their labels to include the same boxed warning highlighting the potential for increased risk of cardiovascular (CV) events and gastrointestinal (GI) bleeding associated with their use. Manufacturers of Celebrex and all other prescription NSAIDs will be asked to revise their labeling to include a Medication Guide for patients to help make them aware of the potential for CV and GI adverse events associated with the use of this class of drugs.

Bextra was first approved by the FDA in November, 2001. Since then it is estimated that over 7 million patients worldwide have taken Bextra, and that 12.9 million prescriptions were written last year alone. This resulted in approximately $1.5 billion in Bextra sales for Pfizer just last year.

Since the approval of Bextra, all NSAIDs and COX-2 inhibitors have come under the scrutiny of the medical community. Several studies have shown an increased risk of heart attacks, strokes and other cardiovascular events in patients taking Bextra. Additionally, the FDA has cited an increased risk for gastrointestinal bleeding and life threatening skin reactions, including Stevens Johnson Syndrome (SJS).

Bextra side effects sometimes include:

  • Abdominal pain, tenderness, or discomfort
  • Bloody, black, or tarry stools
  • Nausea or heartburn
  • Bloody vomit
  • Unexplained weight gain
  • Swelling or water retention
  • Unusual fatigue or lethargy
  • Yellowing of the skin or eyes
  • Flu-like symptoms
  • Unusual bruising or bleeding

Studies have indicated that those at higher risk for dangerous Bextra side effects include patients immediately post-operative from cardiovascular bypass surgery (CABG) and people who have coronary artery disease (people who have known angina or who have had a heart attack), people who have cerebrovascular disease (people who have had a stroke or who currently have episodes known as TIA (transient ischemic attacks)), and people with a history of stomach ulcers.

If you are currently taking Bextra,
you should immediately contact your doctor to discuss alternative medication. Any decision about which drug product to take to treat your symptoms should be made in consultation with your physician based on an assessment of your specific treatment needs.

If you have been injured by Bextra the manufacturer may have failed in its duty to design, make, inspect and label the product appropriately.

Brown & Crouppen has been building a reputation for success with personal injury clients for almost 25 years. Today, we are one of mid-America’s largest personal injury law firms with over 70 legal professionals and five offices throughout Missouri and Illinois. Brown & Crouppen has thrived because of our shared commitment to deliver the best possible service to clients throughout Missouri and the United States. A large area of our concentration is dangerous drug litigation involving manufacturers and suppliers of unsafe drugs and products.

Contact our experienced injury attorneys today for a FREE claim evaluation. Contact Us Online, or call: 1(800)536-HELP

 
 
Free Bextra Legal Claim Evaluation reviewed by Prescription Drug Attorneys
 
Name:


Phone:


Email:
 

How Did You Find Us?

Comments / Questions:
Contact Our Missouri Lawyers today for a Free Bextra Evaluation
BEXTRA INFORMATION  BEXTRA FAQs  |  DRUG FACT SHEET  |  NEWS UPDATES  |  OUR ATTORNEYS
FREE CLAIM EVALUATION  |  CONTACT US  |  LINKS & RESOURCES  |  HOME

Copyright - 2005 - Bextra - Attorneys .com & Missouri Lawyers of Brown & Crouppen
Dangerous Prescription Drug Information: Bextra, Legal Rights, Lawsuits, Side Effects, FDA
Recall, Drug Withdraw Info and Pharmaceutical Negligence Legal Representation

Website by Consultwebs.com  |  Webs for Lawyers & Law Firms